Search for: "About Inc" Results 161 - 180 of 66,756
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Oct 2009, 6:03 am
Little information was dispensed yesterday by the California stem cell agency about the first step in what is proposed to be a $500 million loan program for the biotech industry.But a biopharmaceutical industry blogger provided some information about the $20 million loan to Novocell, Inc., a San Diego stem cell engineering company with an emphasis on diabetes therapies. [read post]
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending September 30, 2008. [read post]
19 Jan 2013, 5:04 pm by David Jensen
” Concerns about conflicts of interest have long been of concern to observers of the stem cell agency for years. [read post]
11 Mar 2019, 12:20 pm by Renae Lloyd
Investigation Are you concerned about your investment in Carey Watermark Investors Inc.? [read post]
26 Mar 2011, 8:49 am
DiMare Ruskin, Inc., a large agricultural business with operations in California and Florida, violated federal law by subjecting female employees to sexual harassment by their supervisors and retaliating against them for complaining about it, the U.S. [read post]
4 Jan 2016, 7:49 am by Law Offices of Jeffrey S. Glassman
Ortho-McNeil-Janssen Pharma., Inc: Defective Drug Lawsuits appeared first on Product Liability Lawyer Blog. [read post]
19 Jun 2019, 7:10 am by Stacey Lantagne
Continuing the theme of thinking about fall courses, a recent case out of the Western District of Washington, Phytelligence, Inc. v. [read post]
The attorneys at Eccleston Law have launched an investigation of OppenheimerFunds Inc. in response to the firm being ordered by the Securities and Exchanges Commission (“SEC”) to pay over $35 million in fines for making misleading statements to investors about struggling mutual funds during the 2008 credit crisis. [read post]